Member Info for lordloadsoflolly

Seamanp911 - I'm sure we'd all like to attend your £1 party next year. Any particular date in mind? Either way, put me down for two tickets please. But just before then, perhaps you could share the detailed calculations you've done to arrive at your figure of £1? Just so we all ensure the party doesn't get rained off.

Walp - I agree with your final comment about Moderna, but don't think you can compare their Covid business to Astra Zeneca's. The latter initially adopted a not-for-profit price model & kept this going for some time. Moderna did not.

Baf3 - Fortunately, it seems I can read marginally better than you can write. It's "well done", not "we'll done".

Anyhow, as a TEK shareholder, I've no agenda whatsoever & hope the discount will eventually narrow between market cap & sum-of-parts valuation. As you say, market valuations have changed. But so too has the backdrop of high interest rates & high (if currently slightly falling) inflation. With that, growth/speculative stocks have taken a back seat, whilst "value" shares have come more to the fore. Unless/until interest rates start falling significantly, I'm not convinced growth shares will move closer to their historical valuations any time soon.

Your argument that "the market needs true valuations to create real volume" makes no sense at all to me. A true valuation is whatever the market dictates. Not what you or I would like it to be. Every transaction needs two parties to be concluded - a buyer and a seller. So it's much more likely that a wide SPREAD would impact sales volumes than what you consider an undervalued price.

I've progressed well beyond Rosie and Jim level 2 thanks. Perhaps you should revisit it though. Might help you improve your spelling & grammar.

TopCatz, Tivman & Baf3 - Microsalt has patented their process, so hopefully it's watertight as you suggest. I doubt other manufacturers looking to incorporate Microsalt into their own products would concern themselves with this unduly. It's ultimately Microsalt's issue, not theirs. If another company came along and found a way round Microsalt's patents, those other food producers would likely just switch allegiance.

Baf3 - yes I can read thanks. But for the reasons above, I disagree with your conclusion that"it's a given their IP is solid." I'm not saying it isn't. Just that they haven't shown conclusively either way yet. As Tivman suggests, hopefully the IPO info will cover this off. My "negative agenda" - as you term it - is borne out by TEK's share price movement over the past couple of years. Your optimism largely appears to be based on Microsalt's forthcoming IPO + Bell's update turbo-charging TEK's share price. It may do - here's hoping. But as we saw with Lucyd, it's not a given. However much the optimists suggest otherwise.

TopCatz - you suggested I might like to comment on TEK's RNSs, so here goes!

Today's reiterates some positive previous announcements. That said, I've not spotted anything new. Nor has the market by the looks of things, as TEK's share price hasn't budged so far.

I think Microsalt's potential could be huge. My main concerns are a) whether they've ever spelt out how well their IP is protected. And b) How much research they've done to benchmark their product against existing low sodium alternatives. There are already plenty of cheap salt products on the market, offering comparable - if not lower - sodium content. Just Google "low sodium salt". And whilst I understand these have a totally different composition (by adding potassium chloride), I'm not sure the average consumer will understand this. Or care that much, providing they still rate the flavour. I believe Saxa also worked on salt crystal size reduction some years ago. And whilst they didn't get it down to Microsalt's micron size, they did reduce it significantly. How would Microsalt be able to stop big players launching future lookalikes with a slightly different particle size?

TEK's impending update on Guident is certainly intriguing. The fact their RNS misspells it (referring to Guidant) is sloppy & less than reassuring.

If your broker handles shares on the Aquis exchange, then yes - you can cash them in. They've a huge spread though (currently Bid 7p, Ask 11p), as Aquis is very illiquid. SOH has talked of migrating them to AIM within the next year or so. In which case their liquidity & price would likely improve. So if you can afford to delay, it might be worth waiting to see if this happens.

Healthy scepticism always good! Opinions vary on this board about SMT's prospects. And we can't all be right. So - as ever - it's important to weigh up all the arguments & draw your own conclusions. But I'd agree most of the regular posters on here are, at least, civil, well-informed & well-intentioned. Sadly Sugarbabe wasn't.

TopCatz - I'll certainly post as soon as I see a significant RNS from TEK - you know, one that's actually likely to move the dial (upwards) in terms of TEK's share price. Microsalt might just be that cataylst. Not sure why you continue to dismiss facts which you admit are pertinent to the US, when Guident & Lucyd are both US-based companies.

TopCatz - it's got nothing to do with being boring. I'm just stating a fact. Did you actually read the article I linked to? Thought not. It said: "The September effect is not limited to U.S. stocks but is also associated with some worldwide markets". In any case, whilst TEK is an AIM share, its current listed holdings are all US-based. I'm not trying to talk TEK down here, just saying that September might offer a better price to buy, if anyone's interested.

Sugarbabe posted under several different tags. Which is maybe why LSE showed him/her the door. That said, their ADVFN posts vanished at exactly the same time. So maybe, as I suggested, they simply got bored of nobody listening to them & skedaddled. Good riddance either way,

TopCatz - True. However, I prefer facts to old wives' tales! https://www.investopedia.com/ask/answers/06/septworstmonth.asp#:~:text=One%20of%20the%20historical%20realities,indexes%20usually%20perform%20the%20poorest.

TopCatz - hope you're right, but September is normally one of the worst months for markets. Early autumn is often when I try to invest any spare cash, as sentiment always seems to take a nosedive then. Reckon it's got something to do with post- summer holiday blues (& bills) kicking in.

Sugarbabe - in case you were wondering, this board is meant to be about Scottish Mortgage. BG manages several different funds, many of which have very different risk profiles & objectives from SMT. I don’t plan to waste any further time reasoning with you, so won’t be responding further. Looks like you’ll just have to preach to an empty room from now on, as I feared - & predicted. Enjoy!

Sugarbabe posted on 11 Aug: “I should jettisoned this stock at 7.38 and never looked back. Moderna...big performance drag. Non public Companies...30%... performance drag. Illumina... performance drag. Current managers... performance drag.”

Then just 2 days later Sugarbabe announces: “ I am selling £10k in a fund and I am going to plonk it in here...or Legal& General for dividends, but I erring towards SMT..”

Sure, SMT’s price has dropped back a bit in August, but the investment strategy still doesn’t look very consistent or well thought through. Any more than the grammar used. Which is odd when this poster allegedly scours the pages of the FT every day.

Not that this should come as a great surprise to anyone. Sugarbabe also mentioned Molten Ventures as a speculative buy. You know, the same Molten Ventures that’s lost investors money over 1 year, 3 years, 5 years. Even over 7 years since launch.

People are free to post whatever they like - preferably in a civil fashion & remaining within the law. But some posters strike me as more reliable than others.

Sugarbabe - you've only been posting for 4 days, yet have already been pretty abusive & dismissive of others on here with far longer track records - & arguably a bit more experience. Hardly a way to win friends & influence people. Fine to disagree & express a different view, but always best to remain civil, I'd suggest. So maybe try to dial it down a bit. Otherwise you'll likely find you're talking to an empty room. Ta.

ShortWhacker - you on wacky baccy or summat?

Agricore - yes, agreed we should ignore each other from now on. Have a good life.

Increased interim dividend of 6.5p (up 30% - LY 5p) payable on 6 October 2023 to shareholders on the register at the close of business on 8 September 2023.

Agricore - I wasn't going to respond, but just couldn't ignore your latest drivel.

So, Edison produces a bit of research (a.k.a. paid for sales promotion) for their client Molten Ventures (GROW).

Seeing as Molten Ventures is a European VC fund paying Edison £60K p.a. for producing a bit of PR spin - er sorry, detailed research - Edison unsurprisingly accentuates the positives in their client's portfolio holdings.

Which would be great, but for three things:

a) On a 1, 5, or even 7 year timescale since launch, Molten Ventures has been an appalling investment, consistently losing money over each of these periods: https://www.google.com/search?q=grow+share+price

b) It only has around 70 direct holdings, so is hardly representative of the market as a whole

c) In any case, who cares whether early stage companies are achieving more 'up' than 'down' rounds? Greater fool theory & all that. All that really matters to Molten Ventures / TEK shareholders is whether their company (helping finance all these funding rounds through investment/dilution) is actually benefitting. And the answer is a resounding NO, judging by the current share price chart of both GROW (presumably ironically named?) & TEK.

Sugarbabe - being in the red shouldn't be a barrier to jettisoning one share in favour of another. If a £1000 investment in share X reduced to £700 and you couldn't see it recovering any time soon, why wouldn't you cut your losses, reinvesting in an alternative share you were more confident about? I'm not saying you should do this with SMT. I'd argue the opposite right now in fact. But as a point of principle, it doesn't ALWAYS pay to hang on in the hope of a recovery.